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Purpose: Endovenous laser treatment is a minimally invasive technique for ablation of the incompetent great (GSV) and
small saphenous vein (SSV). Compared with theGSV, fewer data are available on SSV laser ablation and are not validated.
This multicenter prospective study evaluated the feasibility, safety, and efficacy of endovenous laser ablation to treat SSVs.
Methods: Between January 2003 and January 2007, 204 patients (229 limbs) with CVD and incompetent SSVs (evaluated
by the CEAP classification) who were eligible for surgery underwent consecutive laser ablation procedures. Many
required additional treatment for varicose tributaries and perforator veins with phlebectomy and foam sclerotherapy,
Energy was delivered to the vein wall by a 600-m optical fiber using 810-nm or 980-nm diode laser. Ablations were
performed with duplex ultrasound (DU) guidance and tumescent anesthesia. Follow-up was with clinical examination
and DU imaging.
Results:DU imaging showed immediate occlusion of the SSVwith no thrombosis in the proximal veins. No complications
occurred intraoperatively. All patients had postoperative ecchymosis, but it was minimal. Three patients had distal
thrombotic complications. Superficial phlebitis after complementary surgery occurred in three cases. Complete occlusion
with absence of flow<2 months of follow-up was detected in 226 SSV (98.7%). It occurred 22 in patients with large SSV
diameter. Recanalization was found in one patient at 12 months and in two patients at 24 months. Seven limbs had reflux
in previously treated areas, treated segments, and segments in continuity with them. Three underwent an intervention to
correct symptomatic reflux. The other four had no symptoms. After 1 year, eight limbs developed reflux in new locations
and four underwent treatment. Symptoms resolved in most patients soon after the operation. The mean follow-up was 16
months (range, 2-39 months). After 8 to 12 months postprocedurally, the laser-treated veins were fibrotic and almost
indistinguishable on DU imaging from the surrounding tissues. In five patients (2.25%) postoperative paresthesia
occurred>2 to 3 days postoperatively and persisted in the follow-up. No paresthesia occurred in our last series whenever
a larger amount of tumescent cold saline was infused around the vein.
Conclusion: Endovenous laser ablation of the SSV has excellent early and midterm results. The prevalence of thrombosis
and paresthesia is very low. Symptom relief is very good. (J Vasc Surg 2009;49:973-9.)Conventional surgery for small saphenous vein (SSV)
reflux is associated with high recurrence rates (up to 50%),
many resulting from technical and tactical failures.1 Nerve
injury during ligation and stripping of SSV is also high, so
most surgeons avoid stripping the vein and perform only a
high ligation and resection of the incompetent junction.1,2
Sclerotherapy is a low-risk procedure for treating vein reflux
but has failure rates of 14% for SSV diameter 5 mm and
23% for SSV diameter 5 mm.3
There has been significant progress in the use of mini-
mally invasive techniques with thermal energy in treating
incompetent veins. The results of endovenous ablation
techniques have been shown to be at least equal to treat-
ment with stripping, but with fewer adverse events, reduced
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doi:10.1016/j.jvs.2008.11.019recovery time, and increased quality of life scores.4,5 After
the clinical experience of endovenous laser ablation of the
great saphenous vein, we started the laser ablation of the
SSV on April 2002. When enough experience was devel-
oped (9 months) on the treatment of SSV, a prospective
clinical study was designed to test the feasibility, safety, and
efficacy of the endovenous laser ablation.
METHODS
Patients. During a 4-year period, from January 2003
to January 2007, 229 symptomatic limbs with incompetent
SSV in 204 patients underwent laser ablation. Patients were
enrolled in four centers in Italy (Ferrara Day Surgery,
Ferrara; Casa di Cura, Santa Maria Maddalena, Rovigo;
Policlinico San Marco, and Cittadella Socio Sanitaria,
Venice) and one center in France (Henry Mondor Hospi-
tal, Paris). A total of 179 limbs were operated on in the four
Italian centers and 50 limbs in the French center. Opera-
tions were done by two specialists (D. K., J. L. G.). There
were 158 women and 46 men, and their mean age was 59
years (range, 24-93 years).
All patients were studied before the operation by clin-
ical examination and duplex ultrasound (DU) imaging to
assess vein patency. Reflux was determined in the standing
position using manual compression, followed by sudden
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seconds.6 However, our patients had reflux 2.0 seconds
at least one venous segment. The anatomic variation of the
veins, vein diameter, length of the vein segments to treat
with laser, distance of the near vein wall from the skin, vein
tortuosity, DU signs of prior thrombophlebitis, and com-
munication of varicose tributaries with the deep veins were
recorded. The anatomic variations of SSV were classified in
five groups:
● group A: confluence of the SSV with the popliteal vein
at the popliteal fossa, 150 patients (67.6%);
● group B: confluence of the SSV with the femoral vein,
16 patients (6.4%);
● group C: thigh extension of the SSV in the presence of
saphenopopliteal junction, 26 patients (10.5%);
● group D: common trunk of the SSV with the gastroc-
nemial veins, 32 patients (13.3%); and
● group E: absence of saphenopopliteal junction with
SSV thigh extension, five patients (2.2%).
Vein diameter was assessed with DU imaging at cross-
section scanning in the standing position. The mean vein
diameter and range were measured to evaluate postopera-
tive findings and late outcomes. The study excluded SSVs
with a diameter 3 mm and 13 mm.
A further classification of vein diameter was done to
correlate among largest vein diameter and recanalization,
thrombotic complications, and nerve injury rate. Accord-
ingly, the treated SSVs were classified in three groups:
● group 1: 65 patients with vein diameter 3 mm and
6 mm;
● group 2: 113 patients with vein diameter 6 mm and
9 mm; and
● group 3: 51 patients with vein diameter 9 mm and
13 mm.
The minimum distance of the near vein wall from the
skin was 0.4 mm to avoid skin burns or permanent discol-
oration. Selection of the percutaneous entry point to the
incompetent vein was always in respect of this parameter.
All SSVs with 0.4 mm distance of the vein wall from the
skin were excluded from the study.
Tortuosity of the SSV was accepted if mild. Veins with
extreme tortuosity were excluded because negotiation of
the wire and correct positioning of the fiber tip close to the
junctionmight have been difficult. If the vein wall thickness
after DU compression was 2 mm, patients were eligible
for ablation but were excluded in the presence of endolu-
minal acute or chronic thrombus.
Clinical preoperative evaluation also included stratifica-
tion of chronic venous disorders according to the CEAP
classification: 62 patients were in C2, 91 in C3, 37 in C4, 15
in C5, and 24 in C6.
The patients were thoroughly informed about the pro-
cedure, operation risks, recurrence in case of recanalization
of the vein, and the limited amount of available data on the
long-term efficacy of this technique. All patients signed a
written informed consent form before the procedure.During the operation, patients were fully awake in the
prone position. The SSV was punctured in four limbs at the
lateral malleolus and in 225 limbs in its lower third. A 5F
introducer sheath was positioned, and a J-guide wire was
inserted into the SSV and advanced to the saphenopopliteal
junction or at any level in the thigh, depending on the
anatomy of the SSV thigh extension. The sheath was then
withdrawn up to a site mark indicating the last 2 cm of the
laser fiber. The correct position of the fiber tip was con-
firmed by ultrasound imaging. The optical fiber tip was
positioned always 2 to 3 mm below the saphenopopliteal
junction in groups A and B, 2 to 3 mm below the common
trunk with the gastrocnemial veins in group D, and at the
end of the SSV in case of absence of saphenopopliteal
junction (group E). In groups C and E who had thigh
extension of the SSV, the fiber was advanced above the
popliteal fossa only if this segment had reflux. The energy
delivered to the proximal end of the vein was not affected
by the group type.
All patients received local anesthesia with mild sedation
using midazolam (2 to 3 mg) or diazepam (2 mg) before
starting the treatment and preoperative analgesia with ke-
torolac (30 mg) 30 minutes before the procedure. Tumes-
cent anesthesia was infused with an 18-gauge needle under
ultrasound guidance with a mixture of 300 mL of normal
saline and local anesthetics consisting of 2% lidocaine (15
mL) and bicarbonate (10 mL) or neutralized 0.5% mepiva-
caine (100 mL). The solution was infused on both sides of
SSV to separate the sural nerve from the vein (Fig 1). Also,
enough fluid was infused to encircle completely the whole
vein segment to be treated (Fig 2). In the beginning of the
study, 100mL of fluid was infused, but in 2006, 250 to 500
mL was used, depending on the size and length of the
treated SSV. The temperature of tumescent fluid in the last
year of the study was set at 4°C to cause local anesthesia and
significant spasm of the vein and the perivenous vessels.
The SSV in 223 limbs was treated with a 980-nm diode
laser and in six with an 810-nm. Energy was delivered to the
Fig 1. Cross-sectional picture by ultrasound imaging shows the
sural nerve (inside red circle) adjacent to the small saphenous vein.
Tumescent anesthesia is given by placing the needle tangentially in
both sides of the vein to separate it from the nerve.SSV wall in 225 limbs with a 600-m laser optical fiber (Fig
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200-m laser fiber was used in one. Laser energy was always
delivered under DU guidance to make the procedure safe
and assist the vein obliteration. Laser energy was delivered
to the vein wall with a pull-back rate of approximately 40 to
50 J/cm. The mean energy rate was 49.2 J/cm (range,
22.7-96.7 J/cm). The immediate occlusion of the SSV was
confirmed by DU imaging. Lack of compression, echo-
genic material in the lumen, and absence of color flow were
used to document the occlusion (Fig 4).
Complementary surgery, including, phlebectomy, vein
ligation, or injection foam sclerotherapy, was performed to
treat incompetent tributaries and perforator veins. In 40 limbs
no procedure was performed other than the ablation. Only
phlebectomies were performed in 177 limbs, both phlebecto-
Fig 2. Infusion of tumescent anesthesia around the small saphe-
nous vein (SSV). A, The SSV before tumescence has a diameter of
6.2 mm and the catheter inside the vein measures 2.7 mm.B,After
the infusion of the cold tumescent fluid, the diameter of the SSV is
3.4 mm and encircles the catheter.mies of tributaries and ligation of perforators occurred in 8limbs, phlebectomies and foam sclerotherapy of tributaries
were done in 3 limbs, and ligation of perforators and foam
sclerotherapy of tributaries without phlebectomies was done
in 1 limb. In limbs where it was present, great saphenous vein
reflux was always treated before the SSV.
The operation was done in a mean time of 23 minutes
(range, 8.5-49 minutes). At the end of the operation, the
limb was wrapped with an elastic bandage for about 2
hours. Afterwards, elastic compression (class II, 20 to 0 mm
Hg elastic stocking) was applied for 15 days. An ice pack was
used immediately on the limb and for 7 consecutive days.
After the operation, all patients received low-molecular-
weight heparin (LMWH) prophylaxis with reviparin sodium
(1750 IU for 7 days) to avoid postoperative risk for thrombo-
sis.7 Postoperative analgesia with nimesulide (100 mg every
12 hours) was given to all patients for 1 week. Themean time
before patient discharge from the hospital or the ambulatory
office was 2 hours (range, 1-4 hours).
The DU and clinical examinations were performed on
the day of the procedure,1week, at 2months, 1 year, and
yearly thereafter (Fig 5). Patients were assessed for deep
Fig 3. Long view of the small saphenous vein during laser abla-
tion. As the catheter is being pulled back, steam bubbles are seen
from the heating of the blood.
Fig 4. The ultrasound image shows the small saphenous vein
immediately after the procedure is occluded. The split screen
function shows the small saphenous vein on the right side is not
compressible after applying pressure with the transducer.venous thrombosis (DVT), nerve injury, recanalization
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resolution of symptoms. The DU examination was per-
formed in the standing position using low-flow settings
(pulse repetition frequency1500Hz and high color gain)
to detect any recanalized segment or reflux with low veloc-
ity. DVT was detected by the noncompressibility of the
vein and filling defects on color mode. Patients were asked
specifically for their symptoms but this was not recorded
using any scales. Change in the clinical grade was docu-
mented with the CEAP classification, but a clinical severity
score was not used. Preoperative, intraoperative, and postop-
erative data were collected prospectively by using a custom-
made database.
A standardized questionnaire (see Appendix, online
only) was used for the symptoms and patient satisfaction.
This was limited to the patients’ opinion, not an evaluation
by the treating physician, and was performed with the
assistance of the support staff.
RESULTS
Of 240 limbs that were treated, 11 were excluded
because of close distance to the skin (n  8) or significant
tortuosity (n  3). Mean diameter of the SSV was 6.4 mm
(range, 4-11 mm), and its junction was 7.2 mm (range,
4-13 mm). Immediate occlusion of the SSV was confirmed
in all limbs. The whole length of the SSVwas treated in only
four patients with ulcers.
No proximal thrombosis, skin burns, or other adverse
reactions occurred intraoperatively. The recanalization rate
and all complications are compiled in Table I and Fig 6.
Postoperative ecchymosis was observed in all patients but
was minimal. Two patients presented immediate recanali-
zation after 1 week and one patient after 2 months, for an
overall rate 1.3%. In these patients themean energy rate was
46.9, 42.3, and 44.1 J/cm, and the SSV diameters before
ablation were 13, 9, and 10 mm, respectively. The recana-
lization rate among limbs with large SSV diameter (group
3) was 5.9%. One patient underwent redo laser ablation
that resulted in permanent occlusion of SSV. This patient
Fig 5. At the 1-year follow-up, a trace of the small saphenous vein
(arrowheads) is barely noticeable inside the canal.sustained a sural nerve injury with consequent permanentnumbness at the lateral malleolus while the energy rate for
ablation was 82 J/cm. A few more recanalizations were
observed throughout the follow-up (Fig 6, A).
Complete resolution of clinical symptoms became evi-
dent soon after the operation. The mean follow-up was 16
months (range, 2-39 months). After 8 or 12 months from
the procedure, the ablated veins were not easily distin-
guished on DU imaging. Echogenic bands were seen along
the course of the ablated veins. Reflux in previously treated
areas was found in seven limbs (Fig 6, B). These include
treated segments and segments in continuity with them.
Three of those limbs underwent an intervention to correct
symptomatic reflux. The other four had no symptoms.
Reflux in new locations away from the treated areas devel-
oped after 1 year in eight limbs (Fig 6,C), and four of those
underwent treatment because of the symptoms. The com-
bined effect of recanalization, reflux in treated areas, and
reflux that developed in new locations is seen in Fig 6, D.
Reflux in treated areas other than the ablated trunk and
reflux in new location has a higher prevalence. The latter
develops at least a year later from the initial treatment.
Postoperative paresthesia from sural nerve injury was
observed in five limbs (2.2%). It occurred 2 to 3 days after
the ablation and persisted in the follow-up. In all cases
numbness of small zones around the lateral malleolus was
present. Hyperesthesia was never observed. The nerve in-
jury occurred in two patients at an energy rate of 57.56 and
79 J/cm. In the other three, there was a prior saphenopo-
pliteal junction ligation, whereas in the last two patients,
phlebectomies was performed together with the ablation.
No paresthesia occurred later in our series when larger
amounts of tumescent cold saline were infused around the
vein.
Calf vein thrombosis without involvement of the prox-
imal veins occurred in three patients. One patient had
deficiency of protein C and S and mutation of factor V, the
second was receiving long-term estrogen therapy for uter-
ine fibroma, and the third had no apparent cause other than
the procedure. In all cases complementary surgery was
performed, consisting of ligation of perforators and phle-
bectomies in two limbs and phlebectomies and foam scle-
rotherapy in one. Superficial thrombophlebitis after com-
plementary surgery occurred in three patients. All patients
were fully recovered after weight-adjusted LMWH therapy.
Patient satisfaction was bad in one patient (recanaliza-
tion after laser ablation and nerve injury after redo surgery),
good in six, and excellent in 197. The patients’ clinical
stage changed in those with C6 to C5 and from C2 to C1 or
C0. Patients with C4 remained at the same class, but C3 was
reduced or eliminated and C2 was abolished. The follow-up
data using the CEAP classification at 6 and 12 months are
compiled in Table II.
DISCUSSION
Treatment of SSV incompetence is important, because
many patients present with skin damage and ulceration.8
This was clear also from the current study, where 76 limbs
(33%) were in CEAP classes 4, 5, and 6. Endovenous laser
D,Re
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standard stripping. Endovenous laser ablation of the SSV in
this study was a feasible and well-tolerated alternative to
standard surgical stripping, with optimum safety and effi-
cacy outcomes. Many of the morbidities of general and
regional anesthesia and open surgery are avoided.
The anatomy of the SSV has great variation; therefore,
Table I. Complications during and after the treatment
Complications
Days
1 (n  229) 7 (n  229) 2 (n 
DVT, No.
Proximal, No. 0 0
Distal, No. 0 3
SVT, No. 0 3
Nerve injury, No. 0 5
Skin burns, No. 0 0
Death, No. 0 0
Symptoms resolved, No. 0 0 20
Ecchymosis, No. 229 229
DVT, Deep vein thrombosis; SVT, superficial vein thrombosis.
100
70
80
90
50
60
30
40
0
10
20
0 1 week 2 m           6 m           12 m       24 m        36 m
229 229 229 225 154 66 53 
Limbs at risk
100
70
80
90
50
60
20
30
40
0
10
0 1 week 2 m 6 m 12 m         24 m        36 m
229 229 229 225 154
Limbs at risk
66 53
A
C
Fig 6. Survival curves for treatment failure and developmen
reflux.B,Reflux in treated areas.C,Reflux in new locations.traditional surgery is technically difficult and as a result maylead to early recurrence.1 Preoperative DU imaging is manda-
tory to assess the distribution and extent of reflux, vein diam-
eter, and anatomy, and also to avoid an incorrect incision at
the popliteal fossa, extensive dissection, and nerve damage.
Laser treatment avoids these problems because it is done
under direct DU guidance without surgical incisions. For this
reason, it is most important that the operator have very good
Months
) 6 (n  225) 12 (n  154) 24 (n  66) 36 (n  53)
0 0 0 0
0 0 0 0
0 0 0 0
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flux in new sites.A,Recanalized segments with and without
canalization, reflux in treated areas and in new locations.229
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t of recatheter skills in laser operations and excellent command of
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optimal outcomes.9
Two recent articles report the use of endovenous laser
treatment for the SSV. In the first, 210 limbs in 187
patients were treated, with a mean follow-up of 4
months.10 Of these patients, 126 had a final follow-up with
DU imaging 2 to 11 months after the procedure that
showed a 96% occlusion rate. One week after the ablation,
12 patients had thrombus in the popliteal vein. The throm-
bus was nonocclusive and had a mean length of 1.5 cm
(range, 0.3-4.0 cm). The five recanalized SSVs had small
flow channels without reflux. Numbness was found at the
lateral malleolus or lower posterior calf in three limbs
(1.6%). Resolution of pain occurred in 96% of limbs among
the 187 limbs that had a follow-up at 6 weeks.
In the second study, 68 limbs in 65 patients underwent
laser ablation of the SSV.2 Occlusion of the SSV at 6 and 12
weeks occurred in all limbs. A 6-month follow-up was
achieved in 46 patients, and in all of them the SSV remained
occluded. Superficial vein thrombosis was found in three
limbs (4.4%) and transient numbness also in three limbs
(4.4%) that resolved in all by 6 months. No DVT occurred.
Our study had longer follow-up (mean, 16 months),
and the results were comparable to the above articles. In
accord with the second study, we did not have any limbs
with proximal vein thrombosis. All our patients received a
prophylactic dose of LMWH, and this may have been the
reason. Patient satisfaction was as high: 197 had an excel-
lent result, six considered it good, and only one said the
result was bad.We believe that our results are based not just
on the SSV ablation but also in the concomitant treatment
of the incompetent tributaries.
From June 2006 to January 2007, a high volume of
tumescent cold saline (250 to 500 mL) was infused mixed
with low doses of local anesthetic agents. This simple
innovation eliminated postoperative paresthesia and had a
drastic reduction on pain in the first 10 days after the
procedure. However, this was a simple observation and was
not documented objectively or in a randomized fashion.
Tumescent anesthesia is a very important part of the pro-
cedure. It facilitates the vein dissection from the perivenous
Table II. Patient evaluation using the CEAP classification
CEAP class Limbs, No. 7 d (n  229)
C2 62 62 in C1
C3 91 40 in C3
51 in C1
C4 37 37 in C4
C5 15 15 in C5
C6 24 24 in C6
NA, Not applicable.
aOne patient died at 6 months from unrelated causes.tissues and can prevent nerve injury.The tumescent anesthesia was performed percutane-
ously through an 18-gauge needle, under DU guidance, to
avoid an accidental puncture of the veins and of the tibial
nerve, which is always visible at the popliteal fossa. The
tibial nerve should always be distanced from the SSV by
injecting a large amount of tumescent fluid between the
nerve and the vein. The same applies to the sural nerve,
which runs together with the SSV. A low volume of tumes-
cence fluid may be inadequate to protect the tibial and sural
nerves from thermal damage. Small arteries near SSV can
also be damaged, leading to arteriovenous fistula forma-
tion.11
Tumescent anesthesia also protects against thermal in-
jury of the skin because it increases the distance of the skin
from the vein. Furthermore, the energy delivery is more
effective because the vein is collapsed around the catheter.
This prevents thrombophlebitis because almost all of the
blood is evacuated from the vein. Only DU-guided tumes-
cence can provide a precise concentric distribution of liq-
uids throughout the length of the treated vein.
The vein diameter after tumescence seems to be one of
the most important factors for the success of the proce-
dure.9,12,13 It provides spasm of the vein around the cath-
eter and protects the perivenous tissues from thermal dam-
age. For this reason, a simple physical method was
introduced to exaggerate the vein spasm and to increase
protection of the perivenous tissues.
The optical tip was placed 2 to 3 mm below the
saphenopopliteal junction or the confluence of the SSV
with the gastrocnemius vein. Unlike the saphenofemoral
junction, the saphenopopliteal junction has no tributaries
and therefore the SSV can be ablated at a shorter distance
from the popliteal and gastrocnemius veins. Because all of
our patients were mobilized immediately after the opera-
tion and were also given LMWH, no popliteal vein throm-
bosis was identified. Under these conditions, it appears to
be safe to ablate the SSV at this level. Although we are
comfortable with this approach, our data need to be con-
firmed by other studies.
Up to 6 months, where all but four patients had a
complete follow-up, there were three recanalizations and
d (n  229) 180 d (n  225) 360 d (n154)
62 in C1 62 in C1 38 in C1
24 NA
7 in C3 6 in C3 57 in C3
84 in C1 85 in C1 34 NA
37 in C4 35 in C4 22 in C4
2 NA 15 NA
15 in C5 14 in C5 0 in C6
1 NA 23 in C5
18 in C6 2 in C6
a 24 in C6
6 in C5 21 in C5 0 in C660no development of new disease. Only one of these three
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zation was found in another three patients, and reflux in
previously treated areas other than the abated trunk was
found in seven. Reflux in new locations was detected in eight
patients at 13 months or later. A third of the patients did not
return for follow-up at 1 year, however, and some of these
patients may have developed new disease. Only one death
occurred, from unrelated causes, at 6 months, and no pulmo-
nary embolism developed. To our knowledge, this is the only
study to report all causes of reflux in SSV ablation throughout
the follow-up. The reflux that developed in treated areas and
in new locations had a higher prevalence than the recanaliza-
tion, and it was themain reason for repeat interventions in the
patients.
Our study used the CEAP system to assess ablation in
the SSV. Downstaging in the CEAP grade was obvious in
the 24 patients in C6 to C5 and in those with C2 to C1 or
C0. Patients with C5, C4, and C3 also had elimination of the
C2 component. Patients in C5 had a scar at the area of the
healed ulcer and clearly remained in the same class. We are
unable to measure changes in the skin of patients in CEAP
class 4; therefore, all patients in this class remained in the
same grade.
Edema was reduced, but this was not measured objec-
tively. Also no particular scales were used for other symp-
toms such as pain, burning sensation, heaviness, and itch-
ing. In most patients, these symptoms were eliminated or
became milder, but this cannot be documented in an
objective manner and are a limitation of this study. Patient
satisfaction was excellent in all but seven, as it was evident
by the questionnaire filled after the treatment. The ques-
tionnaire used was not validated and was designed only for
the postoperative course. A clinical severity score was not
used.
CONCLUSIONS
Endovenous laser treatment of the SSV with concom-
itant treatment of the incompetent tributaries seems to be a
very good alternative to traditional surgery. Early and mid-
term results are excellent, with a very few complications and
recanalization.
We thank Cappellini Marco from Kappe software for
organizing, shorting, and analyzing the data of our pa-
tients.
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April 2009979.e1 Kontothanassis et alAppendix (online only). Patient Questionaire for the Postoperative Control
1) During your trip to home, did you have any problems? Yes ____. No____. If yes, describe the problem.
2) Did you read the doctor’s discharge letter that was given to you at the hospital?
3) Did you understand all the information and postoperative recommendations written in the discharge letter?
4) Did you inform your physician about the operation and the postoperative recommendations?
5) Did you take the analgesic therapy as recommended? If no, explain the reason.
6) Did you have any problems finding the recommended medicines?
7) Did you have pain during the night? If yes, then classify the intensity (1) No pain, (2) Mild, (3) Moderate,
(4) Requiring medication
8) Did you have fever?
9) Did you have nausea?
10) Were the bandages clean?
11) Can you do your normal routine work?
12) Were you satisfied from the medical and paramedical staff?
13) Would you recommend this operation to a friend?
